Rachiotek LLC Receives Major Patent for Spine Stabilization Device
Rachiotek LLC, a medical device company developing the Stabilimax™ Dynamic Spine Stabilization System, a dynamic stabilization device designed to support an injured or degenerated spine without eliminating motion, has received a patent covering a unique way of enabling significant motion of the vertebrae. The Patent, number US 7,931,675 B2, is titled “Dynamic Stabilization Device including Overhanging Member.”
Peter Feinstein, Chairman of Rachiotek commented, “One problem with many dynamic stabilization devices is a lack of space between the pedicles. This lack of space limits the amount of motion allowed by the device and is thought to be critical to clinical performance.” Feinstein added, “To gain space Rachiotek’s new patent describes an overhang of the rod beyond the upper or lower screw of the construct. The overhang ‘creates space’ between the pedicles, potentially increasing the amount of motion that the device permits and enabling clinically relevant motion.”
About Rachiotek LLC and Stabilimax
Rachiotek LLC, headquartered in Wellesley, MA, is developing the Stabilimax™ Dynamic Spine Stabilization System, a posterior dynamic stabilization device designed to support an injured or degenerated spine without eliminating motion. Stabilimax is expected to offer numerous advantages over current spinal fixation products including a less invasive and less traumatic procedure, maintenance of kinematic spine motion and disc function, as well as the potential to prevent or reduce the incidence of adjacent segment disc disease.
Contact: Craig Corrance CEO
Cell – 407-923-0721
Email – email@example.com
Rachiotek LLC, a recently formed Delaware company, has acquired the assets of Applied Spine Technologies Inc., (AST) formerly headquartered in Rocky Hill, CN, the company announced today. Rachiotek plans to continue developing the Stabilimax® Dynamic Spine Stabilization System, a pedicle based posterior dynamic stabilization device designed to support an injured or degenerated spine while maintaining kinematic motion. In particular, the new entity is focused on the completion of critical clinical trials demonstrating the safety and efficacy of the Stabilimax® system. Over 100 patients have been enrolled in the United States to date. In addition, Rachiotek will continue to enhance and enforce the AST patent portfolio while also establishing new CE certification. AST was founded in 2004 in conjunction with Yale University based on the research of Dr. Manohar Panjabi, an acknowledged authority on spinal joint function and its implications for implants.
Stabilimax® is a posterior lumbar spinal stabilization system designed to support an injured or degenerated spine without eliminating motion. It has the potential to maintain kinematic spine motion and disc function, reduce pain and prevent or significantly reduce the risk of adjacent level disc disease. Stabilimax is expected to offer numerous advantages over both current and forthcoming spinal fixation products as well as disc arthroplasty technologies including a much less invasive and less traumatic implant procedure, maintenance of spine motion and disc function, and the potential to prevent or slow adjacent-segment disc disease.